11:39 AM EST - IntelGenx Technologies Corp. : Announced that it has executed a non-binding letter of intent with Tilray, Inc. a global leader in cannabis research, cultivation, production and distribution, to co-develop and commercialize oral film products infused with recreational and medical cannabis (“cannabis-infused VersaFilm™”), in anticipation of amended cannabis regulations which would allow adult-use consumers to purchase edible products. IntelGenx Technologies Corp.
shares V.IGX are trading up $0.40 at $1.50.
